Jodhpur

27 September 2015

TOMATO CUISINES: A DELECTABLE REJOINDER TO THREAT OF CHRONIC AILMENTS?

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Vikram S. Chauhan¹*, Bina Rani², Priyanka Bishnoi³, Raaz K. Maheshwari³¹Department of Botany, SBRM Govt PG College, Nagaur, Rajasthan, India
²Department of Engineering chemistry & Environmental Engineering, Poornima College of Engineering, Jaipur, India
³Department of Chemistry, SBRM Government PG College, Nagaur, Rajasthan, India
*vikkysingh2000@yahoo.com; rkmgreenchem.jaipur@gmail.com

ABSTRACT
With the advent of modern times, stress and pollution have led to major effect on rise of death toll due to chronic diseases. Such diseases are major cause of concern for the medical society. Lycopene, a carotenoid pigment found in tomatoes and its products has antioxidant properties due to the presence of numerous double bonds. Increased consumption of lycopene containing diet has been proposed to offer a protection against many types of cancers and cardio-vascular diseases. Its potential role as nutraceutical has been suggested in many studies. The present review deals with fundamental biochemistry, bio-availability and benefits of lycopene rich diet and its relation with some chronic diseases like various forms of cancers and cardiovascular diseases.
31 August 2015

State Health Committee invites applications from Pharmacists | 141 Openings

Applications are invited from eligible candidates for post of Pharmacist in given districts under national health mission.

Post: Pharmacist
28 June 2015

Detailed info. on Pharmacists (36 posts) vacancies at Border Security Force

Applications are invited from male & female Indian citizens for appointment of following posts (Group 'B' & 'C' Combatised) for Para Medical Staff in the Border Security Force, Ministry of Home Affairs, Government of India. The post is temporary but likely to become permanent.

Post: ASI (Pharmacist- Qualified) (Group-C Post)
23 June 2015

Career as MR in Leading Pharma Company- Nextus

Nextus is a dynamic organization offering Strategic Management & HR Consulting Solutions. We offer a range of services covering Business Consultancy, Communication Planning, Recruitment & Training. With a focused Pharmaceutical & Healthcare Industry Practice, Nextus is one of fastest growing Strategic Business Consultancy companies in India, with comprehensive Recruitment & Training solutions. We bring deep, functional expertise to focus on client’s critical issues and opportunities. Our systematic and result-oriented approach helps our clients achieve their goals in cost-effective and timely manner.

Post: Medical Representative
26 April 2015

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Suresh Rewar¹*, Dashrath Mirdha², Prahlad Rewar³
¹Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
²Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
³Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
sureshrewar1990@gmail.com

ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.
24 April 2015

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

ABOUT AUTHORS:
Suresh Rewar¹*, Dashrath Mirdha², Prahlad Rewar³
¹Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
²Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
³Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
sureshrewar1990@gmail.com

ABSTRACT
A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.
17 February 2015

Opening for Junior Chemist in FAGMIL

FCI Aravali Gypsum & Minerals India Limited (FAGMIL) is Government of India undertaking under the Ministry of Chemical & Fertilizers. FAGMIL was earlier a part of Fertilizer Corporation of India Ltd., functioning as Jodhpur Mining Organization. It is engaged in Mining & exploration of mineral Gypsum.

Post: Jr. Chemist
20 April 2014

IMPACT OF OBESITY ON PULMONARY FUNCTION TEST IN SCHOOL CHILDREN

About Authors:
Madhuri Sharma*¹, KC Mathur¹, Rajnee², Raaz K Maheshwari³
¹Department of Physiology, Sardar Patel Medical College, Bikaner, Rajasthan
²Department of Physiology, Sarojini Naidu Medical College, Jodhpur, Rajasthan
³Department of Chemistry, SBRM Govt PG College, Nagaur, Rajasthan
*madhurisharma26@gmail.com

Abstract
Pulmonary function test are affected by the obesity. Various studies demonstrate important modifications in the pulmonary function tests of obese adults and adolescents, there is scarce information on obese children, and the findings remain inconclusive. Although there are some studies which demonstrate important modifications in the respiratory pattern of obese children, but there are some contradictory findings. So such type of study should be done which give us different and separate findings for overweight, mild obese, moderately obese, and morbidly obese criteria in obese school children in comparison with age, sex and ethnically matched control group.
20 April 2014

Require D.Pharm/B.Pharm as Pharmacists Grade II (27 posts) @ All India Institute of Medical Sciences

Applications are invited in the prescribed proforma from suitable candidates for filling up following Group ‘C’ posts on DIRECT RECRUITMENT BASIS in All India Institute of Medical Sciences, Basni Phase 2, Jodhpur (Rajasthan)-342005.
The essential qualification, experiences etc. required for applying for these posts are as under:

Post: Pharmacist Grade II
16 January 2014

MICROSPHERES AS HYDRODYNAMICALLY BALANCE SYSTEM

{ DOWNLOAD AS PDF }

About Authors:
Rohit Kumar Ahuja*¹, Surendra Singh Saurabh¹, Poonam Choudhary¹, Aniket Singh Chouhan¹, Kamal Singh Rathore²
¹ Lachoo Memorial College of Science and Technology (Pharmacy Wing) Sector-A, Shastrinagar, Jodhpur (Raj.) 342003, IND.
²BN Institute of Pharmaceutical Sciences, Udaipur (Raj.) 313002, India
rohitahuja1111@gmail.com

Abstract:
To build up an oral drug delivery system, it is essential to optimize both release rate of drug and residence time of system within gastrointestinal tract. In oral path difference in gastric physiology such as gastric pH and motility display variability on gastric residence time (GRT) and drug delivery actions. Several approaches are currently utilized in the prolongation of the GRT including hydrodynamic balance systems (HBS), swelling and expanding systems, polymeric bioadhesive systems, high-density systems, modified-shape systems and other delayed gastric emptying devices.One such approach is Floating Microspheres (Hollow Microspheres). Floating microspheres are gastro-retentive drug delivery systems based on non-effervescent approach. These microspheres are characteristically free flowing powders made of proteins or synthetic polymers, ideally having a size less than 200 micrometer. Gastro-retentive floating microspheres are low-density systems that have sufficient buoyancy to float over gastric contents and remain in stomach for prolonged period. The drug is released slowly at desired rate resulting in increased gastric retention with reduced fluctuations in plasma drug concentration. Floating microspheres improve patient compliance by decreasing dosing frequency and better therapeutic effect of short half-life drugs can be achieved. Floating microspheres are characterized by their micromeritic properties such as particle size, tapped density, compressibility index, true density and flow properties including angle of repose, scanning electron microscopy, in vitro floatability studies, in vitro drug release studies and stability studies etc.